Compare

Up to four compounds, side by side.

Useful for choosing between similar peptides or planning a stack.

Add a peptide
Attribute
Senolytic Peptide
FOXO4-DRI
SummaryTargeted senolytic — clears 'zombie cells' in pre-clinical models.
MechanismDisrupts FOXO4-p53 interaction in senescent cells, triggering their apoptosis.
Top outcomes
  • Longevity70
Evidenceanecdotal
Half-lifeUnclear in humans
Administrationsubq
Legal statusresearch only
SafetyUnknown long-term human safety.
PepVault

An outcome-driven reference for modern peptides. Educational only — not medical advice, not a sales platform, not affiliated with any clinic.

Disclaimer: PepVault is an educational resource. Nothing on this site is medical advice. Many peptides discussed are research compounds and are not approved by the FDA or equivalent agencies. Always consult a qualified clinician before starting any protocol.

© 2026 PepVault